Immediate Impact
3 by Nobel laureates 5 from Science/Nature 73 standout
Citing Papers
Ruthenium-Based Photoactivated Chemotherapy
2023 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
Works of Berwin A. Turlach being referenced
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Berwin A. Turlach | 651 | 93 | 19 | 367 | 262 | 80 | 2.0k | |
| Brani Vidaković | 445 | 200 | 5 | 251 | 211 | 117 | 2.8k | |
| Theofanis Sapatinas | 537 | 154 | 6 | 496 | 121 | 56 | 2.5k | |
| Jianhua Z. Huang | 908 | 180 | 11 | 356 | 162 | 60 | 1.9k | |
| Lukas Meier | 805 | 50 | 9 | 443 | 283 | 35 | 2.2k | |
| Peter G. Craven | 683 | 162 | 14 | 289 | 255 | 26 | 2.5k | |
| David M. Allen | 700 | 129 | 19 | 321 | 74 | 97 | 3.1k | |
| Vladimir Spokoiny | 1174 | 285 | 1 | 565 | 264 | 98 | 2.4k | |
| Yang Feng | 808 | 65 | 5 | 518 | 124 | 107 | 2.5k | |
| J. S. Marron | 1085 | 214 | 5 | 584 | 130 | 69 | 2.5k | |
| Dennis D. Cox | 513 | 130 | 366 | 101 | 94 | 2.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...